FMED holdings
Fidelity Disruptive Medicine ETF
Positions
70 stored of 70 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity Revere Street Trust Fidelity Securities Lending Cash Central Fund | US31635A3032 | 31635A303 | 10.266% | $4.2M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 2 | UCB SA | BE0003739530 | Not reported | 4.732% | $1.9M | Equity (common) | Corporate | Belgium | EUR |
| 3 | LIFESTANCE HEALTH GROUP INC | US53228F1012 | 53228F101 | 4.273% | $1.8M | Equity (common) | Corporate | United States | USD |
| 4 | DANAHER CORP | US2358511028 | 235851102 | 3.421% | $1.4M | Equity (common) | Corporate | United States | USD |
| 5 | 10X GENOMICS INC | US88025U1097 | 88025U109 | 3.108% | $1.3M | Equity (common) | Corporate | United States | USD |
| 6 | INTUITIVE SURGICAL INC | US46120E6023 | 46120E602 | 2.918% | $1.2M | Equity (common) | Corporate | United States | USD |
| 7 | COGENT BIOSCIENCES INC | US19240Q2012 | 19240Q201 | 2.852% | $1.2M | Equity (common) | Corporate | United States | USD |
| 8 | ALNYLAM PHARMACEUTICALS INC | US02043Q1076 | 02043Q107 | 2.794% | $1.1M | Equity (common) | Corporate | United States | USD |
| 9 | ARGENX SE ARGENX SE SPONSORED ADR | US04016X1019 | 04016X101 | 2.785% | $1.1M | Equity (common) | Corporate | Netherlands | USD |
| 10 | LEGEND BIOTECH CORP LEGEND BIOTECH CORP SPON ADR | US52490G1022 | 52490G102 | 2.294% | $940K | Equity (common) | Corporate | Cayman Islands | USD |
| 11 | UNITEDHEALTH GROUP INC | US91324P1021 | 91324P102 | 2.250% | $922K | Equity (common) | Corporate | United States | USD |
| 12 | BIO TECHNE CORP | US09073M1045 | 09073M104 | 2.243% | $919K | Equity (common) | Corporate | United States | USD |
| 13 | ASCENDIS PHARMA A/S | DK0060615755 | Not reported | 2.114% | $866K | Equity (common) | Corporate | Denmark | USD |
| 14 | EDWARDS LIFESCIENCES CORP | US28176E1082 | 28176E108 | 2.110% | $865K | Equity (common) | Corporate | United States | USD |
| 15 | MODERNA INC | US60770K1079 | 60770K107 | 2.105% | $863K | Equity (common) | Corporate | United States | USD |
| 16 | KYMERA THERAPEUTICS INC | US5015751044 | 501575104 | 1.987% | $814K | Equity (common) | Corporate | United States | USD |
| 17 | XENON PHARMACEUTICALS INC | CA98420N1050 | 98420N105 | 1.919% | $786K | Equity (common) | Corporate | Canada | USD |
| 18 | HEARTFLOW INC | US42238D1072 | 42238D107 | 1.890% | $774K | Equity (common) | Corporate | United States | USD |
| 19 | SARTORIUS STEDIM BIOTECH | FR0013154002 | Not reported | 1.842% | $755K | Equity (common) | Corporate | France | EUR |
| 20 | INSMED INC | US4576693075 | 457669307 | 1.794% | $735K | Equity (common) | Corporate | United States | USD |
| 21 | VEEVA SYS INC VEEVA SYS INC CL A | US9224751084 | 922475108 | 1.782% | $730K | Equity (common) | Corporate | United States | USD |
| 22 | VAXCYTE INC | US92243G1085 | 92243G108 | 1.765% | $723K | Equity (common) | Corporate | United States | USD |
| 23 | REVOLUTION MEDICINES INC | US76155X1000 | 76155X100 | 1.731% | $709K | Equity (common) | Corporate | United States | USD |
| 24 | CARIS LIFE SCIENCES INC | US1421521071 | 142152107 | 1.713% | $702K | Equity (common) | Corporate | United States | USD |
| 25 | CRINETICS PHARMACEUTICALS INC | US22663K1079 | 22663K107 | 1.648% | $675K | Equity (common) | Corporate | United States | USD |
| 26 | AXSOME THERAPEUTICS INC | US05464T1043 | 05464T104 | 1.575% | $645K | Equity (common) | Corporate | United States | USD |
| 27 | CYTOKINETICS INC | US23282W6057 | 23282W605 | 1.548% | $634K | Equity (common) | Corporate | United States | USD |
| 28 | VERACYTE INC | US92337F1075 | 92337F107 | 1.540% | $631K | Equity (common) | Corporate | United States | USD |
| 29 | THERMO FISHER SCIENTIFIC INC | US8835561023 | 883556102 | 1.534% | $628K | Equity (common) | Corporate | United States | USD |
| 30 | BRIGHTSPRING HEALTH SERVICES INC | US10950A1060 | 10950A106 | 1.533% | $628K | Equity (common) | Corporate | United States | USD |
| 31 | PRIVIA HEALTH GROUP INC | US74276R1023 | 74276R102 | 1.476% | $605K | Equity (common) | Corporate | United States | USD |
| 32 | BOSTON SCIENTIFIC CORP | US1011371077 | 101137107 | 1.437% | $589K | Equity (common) | Corporate | United States | USD |
| 33 | NATERA INC | US6323071042 | 632307104 | 1.425% | $584K | Equity (common) | Corporate | United States | USD |
| 34 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | GB00BRXB0C07 | Not reported | 1.417% | $581K | Equity (common) | Corporate | United Kingdom | USD |
| 35 | GUARDANT HEALTH INC | US40131M1099 | 40131M109 | 1.385% | $567K | Equity (common) | Corporate | United States | USD |
| 36 | STRYKER CORP | US8636671013 | 863667101 | 1.364% | $559K | Equity (common) | Corporate | United States | USD |
| 37 | VIRIDIAN THERAPEUTICS INC | US92790C1045 | 92790C104 | 1.337% | $548K | Equity (common) | Corporate | United States | USD |
| 38 | ALIGNMENT HEALTHCARE INC | US01625V1044 | 01625V104 | 1.248% | $511K | Equity (common) | Corporate | United States | USD |
| 39 | LONZA GROUP AG | CH0013841017 | Not reported | 1.220% | $500K | Equity (common) | Corporate | Switzerland | CHF |
| 40 | NUVALENT INC NUVALENT INC-A | US6707031075 | 670703107 | 1.213% | $497K | Equity (common) | Corporate | United States | USD |
| 41 | STOKE THERAPEUTICS INC | US86150R1077 | 86150R107 | 1.182% | $484K | Equity (common) | Corporate | United States | USD |
| 42 | DISC MEDICINE INC | US2546041011 | 254604101 | 1.176% | $482K | Equity (common) | Corporate | United States | USD |
| 43 | DEXCOM INC | US2521311074 | 252131107 | 1.176% | $482K | Equity (common) | Corporate | United States | USD |
| 44 | INSULET CORP | US45784P1012 | 45784P101 | 1.101% | $451K | Equity (common) | Corporate | United States | USD |
| 45 | ELI LILLY and CO | US5324571083 | 532457108 | 1.065% | $436K | Equity (common) | Corporate | United States | USD |
| 46 | ENLIVEN THERAPEUTICS INC | US29337E1029 | 29337E102 | 1.034% | $424K | Equity (common) | Corporate | United States | USD |
| 47 | CYTOMX THERAPEUTICS INC | US23284F1057 | 23284F105 | 0.985% | $403K | Equity (common) | Corporate | United States | USD |
| 48 | WAYSTAR HOLDING CORP | US9467841055 | 946784105 | 0.981% | $402K | Equity (common) | Corporate | United States | USD |
| 49 | IRHYTHM TECHNOLOGIES INC | US4500561067 | 450056106 | 0.965% | $395K | Equity (common) | Corporate | United States | USD |
| 50 | KESTRA MEDICAL TECHNOLOGIES INC | BMG524411052 | Not reported | 0.955% | $391K | Equity (common) | Corporate | Bermuda | USD |
| 51 | NEWAMSTERDAM PHARMA COMPANY NV | NL00150012L7 | Not reported | 0.914% | $375K | Equity (common) | Corporate | Netherlands | USD |
| 52 | AMYLYX PHARMACEUTICALS INC | US03237H1014 | 03237H101 | 0.825% | $338K | Equity (common) | Corporate | United States | USD |
| 53 | ROIVANT SCIENCES LTD | BMG762791017 | Not reported | 0.823% | $337K | Equity (common) | Corporate | Bermuda | USD |
| 54 | ALIGN TECHNOLOGY INC | US0162551016 | 016255101 | 0.795% | $326K | Equity (common) | Corporate | United States | USD |
| 55 | REPLIGEN CORP | US7599161095 | 759916109 | 0.752% | $308K | Equity (common) | Corporate | United States | USD |
| 56 | ZAI LAB LTD ZAI LAB LTD UNSPNRD ADR | US98887Q1040 | 98887Q104 | 0.659% | $270K | Equity (common) | Corporate | Cayman Islands | USD |
| 57 | MIRUM PHARMACEUTICALS INC | US6047491013 | 604749101 | 0.543% | $222K | Equity (common) | Corporate | United States | USD |
| 58 | UPSTREAM BIO INC | US91678A1079 | 91678A107 | 0.508% | $208K | Equity (common) | Corporate | United States | USD |
| 59 | RELAY THERAPEUTICS INC | US75943R1023 | 75943R102 | 0.446% | $183K | Equity (common) | Corporate | United States | USD |
| 60 | STRUCTURE THERAPEUTICS INC STRUCTURE THERAPEUTICS INC ADR | US86366E1064 | 86366E106 | 0.444% | $182K | Equity (common) | Corporate | Cayman Islands | USD |
| 61 | ZENAS BIOPHARMA INC | US98937L1052 | 98937L105 | 0.441% | $181K | Equity (common) | Corporate | United States | USD |
| 62 | VIKING THERAPEUTICS INC | US92686J1060 | 92686J106 | 0.433% | $178K | Equity (common) | Corporate | United States | USD |
| 63 | PROCEPT BIOROBOTICS CORP | US74276L1052 | 74276L105 | 0.428% | $175K | Equity (common) | Corporate | United States | USD |
| 64 | JANUX THERAPEUTICS INC | US47103J1051 | 47103J105 | 0.419% | $171K | Equity (common) | Corporate | United States | USD |
| 65 | OUTSET MEDICAL INC | US6901452069 | 690145206 | 0.406% | $166K | Equity (common) | Corporate | United States | USD |
| 66 | MBX BIOSCIENCES INC | US55287L1017 | 55287L101 | 0.394% | $161K | Equity (common) | Corporate | United States | USD |
| 67 | OLEMA PHARMACEUTICALS INC | US68062P1066 | 68062P106 | 0.362% | $148K | Equity (common) | Corporate | United States | USD |
| 68 | Fidelity Revere Street Trust Fidelity Cash Central Fund | US31635A1051 | 31635A105 | 0.290% | $119K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 69 | ORUKA THERAPEUTICS INC | US6876041087 | 687604108 | 0.143% | $59K | Equity (common) | Corporate | United States | USD |
| 70 | SPYRE THERAPEUTICS INC | US00773J2024 | 00773J202 | 0.054% | $22K | Equity (common) | Corporate | United States | USD |